U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H31F2N7O4S
Molecular Weight 599.652
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Londamocitinib

SMILES

COC[C@@H](N1CCN(C)CC1)C(=O)NC2=CC=CC3=C2NC=C3C4=NC(NC5=CC=CC(=C5F)S(C)(=O)=O)=NC=C4F

InChI

InChIKey=JNUZADQZHYFJGW-JOCHJYFZSA-N
InChI=1S/C28H31F2N7O4S/c1-36-10-12-37(13-11-36)22(16-41-2)27(38)33-21-8-4-6-17-18(14-31-26(17)21)25-19(29)15-32-28(35-25)34-20-7-5-9-23(24(20)30)42(3,39)40/h4-9,14-15,22,31H,10-13,16H2,1-3H3,(H,33,38)(H,32,34,35)/t22-/m1/s1

HIDE SMILES / InChI

Molecular Formula C28H31F2N7O4S
Molecular Weight 599.652
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 18:28:27 GMT 2023
Edited
by admin
on Sat Dec 16 18:28:27 GMT 2023
Record UNII
JAC34RRR7S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Londamocitinib
Common Name English
londamocitinib [INN]
Common Name English
AZD-4604
Code English
AZD4604
Code English
(R)-N-(3-(5-Fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide
Common Name English
1-Piperazineacetamide, N-[3-[5-fluoro-2-[[2-fluoro-3-(methylsulfonyl)phenyl]amino]-4-pyrimidinyl]-1H-indol-7-yl]-α-(methoxymethyl)-4-methyl-, (αR)-
Systematic Name English
Code System Code Type Description
PUBCHEM
135240395
Created by admin on Sat Dec 16 18:28:27 GMT 2023 , Edited by admin on Sat Dec 16 18:28:27 GMT 2023
PRIMARY
INN
12630
Created by admin on Sat Dec 16 18:28:27 GMT 2023 , Edited by admin on Sat Dec 16 18:28:27 GMT 2023
PRIMARY
CAS
2241039-81-4
Created by admin on Sat Dec 16 18:28:27 GMT 2023 , Edited by admin on Sat Dec 16 18:28:27 GMT 2023
PRIMARY
FDA UNII
JAC34RRR7S
Created by admin on Sat Dec 16 18:28:27 GMT 2023 , Edited by admin on Sat Dec 16 18:28:27 GMT 2023
PRIMARY
Related Record Type Details
OFF TARGET->NON-INHIBITOR
IC50
TARGET -> INHIBITOR
Potent and selective Janus Kinase 1 Inhibitor, an inhaled treatment for respiratory disease.
IC50
TARGET->WEAK INHIBITOR
IC50
TARGET->WEAK INHIBITOR
IC50
BINDER->LIGAND
Percent binding
BINDING
Related Record Type Details
ACTIVE MOIETY